GTM Form 144: Insider to sell 14,290 ZoomInfo shares
Rhea-AI Filing Summary
ZoomInfo Technologies Inc. insider filing reports a proposed sale of 14,290 common shares under Rule 144 through Morgan Stanley Smith Barney LLC on 10/02/2025, with an aggregate market value of $146,758.30 based on outstanding common shares of 318,630,783. The shares were acquired as Restricted Stock Units on 10/01/2025 and show a same-day acquisition and proposed sale timing. The filing identifies prior 10b5-1 sales by James M. Roth on 09/03/2025 of 3,288 shares for gross proceeds of $33,731.59. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Positive
- Timely disclosure of proposed sale through Rule 144 via an established broker
- Inclusion of 10b5-1 history (prior sale of 3,288 shares) provides trading transparency
Negative
- Insider sale of 14,290 shares valued at $146,758.30 could be viewed unfavorably by some investors
- Same-day acquisition and proposed sale (acquired 10/01/2025; proposed sale 10/02/2025) may raise questions about timing
Insights
Insider plans to sell 14,290 shares, totaling $146,758.30.
The filing documents a proposed Rule 144 sale of 14,290 shares via Morgan Stanley Smith Barney on 10/02/2025. The shares were reported as acquired on 10/01/2025 as Restricted Stock Units, indicating recent vesting.
This notice also records prior 10b5-1 sales of 3,288 shares on 09/03/2025 for $33,731.59, showing recent execution activity. The filing itself is procedural disclosure required under securities rules.
Filing includes the required attestation about material information and a trading-plan reference.
The form contains the standard representation that the seller does not possess undisclosed material adverse information and references Rule 10b5-1 sales, which aligns with compliance protocols for planned insider sales.
No statements in the filing assert any undisclosed material facts; the document fulfills statutory notice obligations for the proposed transaction.